Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Continued Endocrine Therapy Is Associated with Improved Survival in Patients with Breast Cancer Brain Metastases.

Bergen ES, Berghoff AS, Medjedovic M, Rudas M, Fitzal F, Bago-Horvath Z, Dieckmann K, Mader RM, Exner R, Gnant M, Zielinski CC, Steger GG, Preusser M, Bartsch R.

Clin Cancer Res. 2019 May 1;25(9):2737-2744. doi: 10.1158/1078-0432.CCR-18-1968. Epub 2019 Jan 15.

PMID:
30647078
2.

My burning issues in the neoadjuvant treatment for breast cancer.

Bergen ES, Bartsch R.

Memo. 2018;11(1):27-30. doi: 10.1007/s12254-017-0378-5. Epub 2017 Dec 22. Review.

3.

Prognostic impact of breast cancer subtypes in elderly patients.

Bergen ES, Tichy C, Berghoff AS, Rudas M, Dubsky P, Bago-Horvath Z, Mader RM, Exner R, Gnant M, Zielinski CC, Steger GG, Preusser M, Bartsch R.

Breast Cancer Res Treat. 2016 May;157(1):91-9. doi: 10.1007/s10549-016-3787-y. Epub 2016 Apr 23.

4.

Breast cancer brain metastases responding to lapatinib plus capecitabine as second-line primary systemic therapy.

Bergen ES, Berghoff AS, Rudas M, Preusser M, Bartsch R.

Anticancer Drugs. 2015 Jun;26(5):579-81. doi: 10.1097/CAD.0000000000000217.

PMID:
25714248

Supplemental Content

Loading ...
Support Center